SI2729473T1 - Derivati karboksilne kisline z oksazolo(5,4-B)piridinskim obročem - Google Patents
Derivati karboksilne kisline z oksazolo(5,4-B)piridinskim obročemInfo
- Publication number
- SI2729473T1 SI2729473T1 SI201230458T SI201230458T SI2729473T1 SI 2729473 T1 SI2729473 T1 SI 2729473T1 SI 201230458 T SI201230458 T SI 201230458T SI 201230458 T SI201230458 T SI 201230458T SI 2729473 T1 SI2729473 T1 SI 2729473T1
- Authority
- SI
- Slovenia
- Prior art keywords
- oxazolo
- carboxylic acid
- acid derivatives
- pyridine ring
- pyridine
- Prior art date
Links
- BFPLMTPHDFFMTG-UHFFFAOYSA-N [1,3]oxazolo[5,4-b]pyridine Chemical group C1=CN=C2OC=NC2=C1 BFPLMTPHDFFMTG-UHFFFAOYSA-N 0.000 title 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11305877 | 2011-07-07 | ||
| EP12305525 | 2012-05-11 | ||
| EP12733131.2A EP2729473B1 (de) | 2011-07-07 | 2012-07-06 | Carbonsäurederivate mit einem oxazolo[5,4-b]pyridinring |
| PCT/EP2012/063297 WO2013004826A1 (de) | 2011-07-07 | 2012-07-06 | Carbonsäurederivate mit einem oxazolo[5,4-b]pyridinring |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2729473T1 true SI2729473T1 (sl) | 2016-03-31 |
Family
ID=46466551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201230458T SI2729473T1 (sl) | 2011-07-07 | 2012-07-06 | Derivati karboksilne kisline z oksazolo(5,4-B)piridinskim obročem |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8580816B2 (sl) |
| EP (1) | EP2729473B1 (sl) |
| JP (1) | JP5984925B2 (sl) |
| KR (1) | KR20140061384A (sl) |
| CN (1) | CN103781790B (sl) |
| AU (1) | AU2012280206B2 (sl) |
| BR (1) | BR112014000100A2 (sl) |
| CA (1) | CA2841220C (sl) |
| CY (1) | CY1117390T1 (sl) |
| DK (1) | DK2729473T3 (sl) |
| ES (1) | ES2562852T3 (sl) |
| HR (1) | HRP20160167T1 (sl) |
| HU (1) | HUE026432T2 (sl) |
| MX (1) | MX365931B (sl) |
| MY (1) | MY164133A (sl) |
| PL (1) | PL2729473T3 (sl) |
| PT (1) | PT2729473E (sl) |
| RU (1) | RU2609002C2 (sl) |
| SI (1) | SI2729473T1 (sl) |
| WO (1) | WO2013004826A1 (sl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9321787B2 (en) | 2011-07-07 | 2016-04-26 | Sanofi | Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring |
| US8907093B2 (en) * | 2011-07-07 | 2014-12-09 | Sanofi | Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO143535C (no) * | 1972-06-14 | 1981-03-04 | Merck & Co Inc | Analogifremgangsmaate ved fremstilling av terapeutisk aktive oxazolopyridiner |
| WO2002092603A1 (en) * | 2001-05-14 | 2002-11-21 | Novartis Ag | Oxazolo-and furopyrimidines and their use in medicaments against tumors |
| AU2004240649A1 (en) * | 2003-05-19 | 2004-12-02 | Irm, Llc | Immunosuppressant compounds and compositions |
| JP2009520688A (ja) * | 2005-11-23 | 2009-05-28 | エピックス デラウェア， インコーポレイテッド | Ｓ１ｐ受容体調節化合物およびそれらの使用 |
| EP1900729A1 (en) * | 2006-09-15 | 2008-03-19 | Novartis AG | Benzoxazoles and oxazolopyridines being useful as Janus kinases inhibitors |
| JP5191497B2 (ja) | 2007-03-21 | 2013-05-08 | エピックス ファーマシューティカルズ，インコーポレイテッド | Ｓ１ｐ受容体調節化合物およびその使用 |
| EP2300481B1 (en) | 2008-05-30 | 2015-09-30 | Merck Sharp & Dohme Corp. | Novel substituted azabenzoxazoles |
| TW201000099A (en) * | 2008-06-20 | 2010-01-01 | Amgen Inc | S1P1 receptor agonists and use thereof |
| AU2009270511B2 (en) | 2008-07-15 | 2013-07-18 | Sanofi | Oxazolopyrimidines as Edg-1 receptor agonists |
| US8907093B2 (en) * | 2011-07-07 | 2014-12-09 | Sanofi | Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring |
-
2012
- 2012-06-25 US US13/532,255 patent/US8580816B2/en active Active
- 2012-07-06 CA CA2841220A patent/CA2841220C/en not_active Expired - Fee Related
- 2012-07-06 HR HRP20160167TT patent/HRP20160167T1/hr unknown
- 2012-07-06 CN CN201280043621.7A patent/CN103781790B/zh active Active
- 2012-07-06 HU HUE12733131A patent/HUE026432T2/en unknown
- 2012-07-06 MY MYPI2014000006A patent/MY164133A/en unknown
- 2012-07-06 SI SI201230458T patent/SI2729473T1/sl unknown
- 2012-07-06 KR KR1020147003226A patent/KR20140061384A/ko not_active Ceased
- 2012-07-06 MX MX2014000024A patent/MX365931B/es active IP Right Grant
- 2012-07-06 PL PL12733131T patent/PL2729473T3/pl unknown
- 2012-07-06 BR BR112014000100A patent/BR112014000100A2/pt not_active IP Right Cessation
- 2012-07-06 RU RU2014104232A patent/RU2609002C2/ru not_active IP Right Cessation
- 2012-07-06 PT PT127331312T patent/PT2729473E/pt unknown
- 2012-07-06 DK DK12733131.2T patent/DK2729473T3/en active
- 2012-07-06 JP JP2014517829A patent/JP5984925B2/ja active Active
- 2012-07-06 AU AU2012280206A patent/AU2012280206B2/en not_active Ceased
- 2012-07-06 ES ES12733131.2T patent/ES2562852T3/es active Active
- 2012-07-06 EP EP12733131.2A patent/EP2729473B1/de active Active
- 2012-07-06 WO PCT/EP2012/063297 patent/WO2013004826A1/de not_active Ceased
-
2016
- 2016-02-24 CY CY20161100150T patent/CY1117390T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012280206A1 (en) | 2014-01-23 |
| JP2014518247A (ja) | 2014-07-28 |
| HRP20160167T1 (hr) | 2016-03-11 |
| PT2729473E (pt) | 2016-03-22 |
| HUE026432T2 (en) | 2016-05-30 |
| AU2012280206B2 (en) | 2016-07-28 |
| BR112014000100A2 (pt) | 2017-01-10 |
| US20130023557A1 (en) | 2013-01-24 |
| WO2013004826A1 (de) | 2013-01-10 |
| HK1192239A1 (zh) | 2014-08-15 |
| KR20140061384A (ko) | 2014-05-21 |
| DK2729473T3 (en) | 2016-02-29 |
| EP2729473B1 (de) | 2015-11-25 |
| CY1117390T1 (el) | 2017-04-26 |
| JP5984925B2 (ja) | 2016-09-06 |
| US8580816B2 (en) | 2013-11-12 |
| CN103781790B (zh) | 2016-04-27 |
| CA2841220C (en) | 2019-07-30 |
| RU2014104232A (ru) | 2015-08-20 |
| EP2729473A1 (de) | 2014-05-14 |
| MX365931B (es) | 2019-06-20 |
| MX2014000024A (es) | 2014-02-27 |
| MY164133A (en) | 2017-11-30 |
| CN103781790A (zh) | 2014-05-07 |
| CA2841220A1 (en) | 2013-01-10 |
| ES2562852T3 (es) | 2016-03-08 |
| PL2729473T3 (pl) | 2016-05-31 |
| RU2609002C2 (ru) | 2017-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL227496B (en) | Pyrazolo[4,3–b]pyridines are converted as drugs | |
| ZA201307783B (en) | Tri-and tetracylic pyrazolo[3,4-b]pyridine compounds as antineoplastic agent | |
| IL234485A (en) | Compounds based on imidazo [2,1 – b] pyridazine | |
| ZA201306542B (en) | 7-azaindole derivatives | |
| TWI562993B (en) | Pyrazoloquinoline derivatives | |
| ZA201306817B (en) | Spirocyclic isoxazoline derivatives as antiparasitic agents | |
| EP2634186A4 (en) | naphthyridine | |
| ZA201206630B (en) | Hetaryl-[1,8]naphthyridine derivatives | |
| ZA201404176B (en) | 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives | |
| IL232717B (en) | 3-cyanoaryl-h1-pyrrolo[b-3,2]pyridine derivatives | |
| ZA201307511B (en) | Pyrido [2,3-b] pyrazine derivatives and their therapeutical uses | |
| IL221479A0 (en) | Triazolo [4,5-b] pyridin derivatives | |
| PL2531505T3 (pl) | Sposób wytwarzania kompleksów 3,7-diaza-bicyklo[3.3.1]nonanu z metalami | |
| ZA201301313B (en) | Herbicidal isoxazolo[5,4-b]pyridines | |
| ZA201404074B (en) | 6-difluoromethyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives | |
| SG11201408816QA (en) | 3-(PYRAZOLYL)-1H-PYRROLO[2,3-b]PYRIDINE DERIVATIVES AS KINASE INHIBITORS | |
| DK2523958T3 (da) | Carboxylsyrederivater med en 2,5,7-substitueret oxazolopyrimidinring | |
| SI2729473T1 (sl) | Derivati karboksilne kisline z oksazolo(5,4-B)piridinskim obročem | |
| PT2729471E (pt) | Derivados do ácido carboxílico com um anel de oxazolo[5,4-d pirimidina | |
| BR112013013282A2 (pt) | compostos de oxazolo[5,4-b]piridin-5-ila | |
| IL235300A0 (en) | A process for the preparation of naphthyridine hist | |
| IL228270A0 (en) | History of 1-h- pyrrolidine -4,2-dione spirocyclics converted in cis-alkoxy | |
| PT2729475E (pt) | Derivados do ácido carboxílico com um anel de oxazolo[4,5-d pirimidina | |
| HK1192238A (en) | Carboxylic acid derivatives with an oxazolo[4,5-c]pyridine ring | |
| PL390846A1 (pl) | Pochodne 5,11-dimetylo-5H-indolo[2,3-b]chinoliny |